Report

  1. Home
  2. Healthcare
  3. Biotechnology

Digital PCR Market / Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, Share & Trends by Offering (Product (Reagents & Consumables, Instrument), Software, Services), Application (Clinical (infectious, Oncology), Research, Forensic, Environmental) - Global Forecast to 2029

Market Report I 2024-07-02 I 599 Pages I MarketsandMarkets

The global digital PCR (dPCR) and real-time PCR (qPCR) market is projected to reach USD 14.8 billion by 2029 from USD 10.0 billion in 2024, at a CAGR of 8.1% during the forecast period of 2024 to 2029. The growth of the Digital PCR (dPCR) and real-time PCR (qPCR) market has been significantly driven by its increasing adoption among hospital and diagnostics laboratories for disease diagnosis application, increasing R&D investment by key players for the development and launch of innovative product and continuous advancements in PCR technologies. However, high instrument costs especially that of dPCR and the technical limitations of PCR are restraining market growth.
"The infectious disease testing segment under clinical application segment accounted for the largest share by application in 2023."
In 2023, the infectious disease testing segment under clinical application segment accounted for the largest share by application in the global digital PCR (dPCR) and real-time PCR (qPCR) market. qPCR has revolutionized infectious disease diagnostics by providing rapid, sensitive, and specific detection of pathogens. It is useful in identifying bacteria, viruses, fungi, and parasites, enabling early diagnosis and effective treatment. During the past decade, clinical laboratories worldwide have been increasing using qPCR for pathogen testing and the diagnosis of infectious and sexually transmitted diseases. Advanced molecular diagnosis tools such as spectroscopy and liquid chromatography are being integrated with qPCR workflows to offer genomic lab technicians the capability of rapid and accurate pathogen detection.
"The US has continued to dominate the digital PCR (dPCR) and real-time PCR (qPCR) market during the forecast period of 2024-2029."
The US is the world's largest biopharmaceutical market and a leader in biopharmaceutical research/investments. The demand for digital PCR (dPCR) and real-time PCR (qPCR) products is expected to grow in the coming years, driven by the rising patient population suffering from infectious disease, increasing focus on biopharmaceuticals, and the need for safe & high-quality products in the healthcare industry. The nation has a highly advanced market in terms of R&D due to the presence of better infrastructure, government support, and private funding. This helps develop innovative and advanced technologies for research. Pharmaceutical companies in the US are actively participating in the development of novel reagent and test assays and utilizing it with Digital PCR (dPCR) and real-time PCR (qPCR), which offers less turnaround time, and is energy-efficient also provide accurate results, with in a span of time. These factors are supporting the growth of the Digital PCR (dPCR) and real-time PCR (qPCR) market in the country.
The primary interviews conducted for this report can be categorized as follows:

- By Respondent: Supply Side- 70% and Demand Side 30%
- By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
- By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%
List of Companies Profiled in the Report:

Danaher Corporation (US)
F. Hoffmann-La Roche Ltd (Switzerland)
Thermo Fisher Scientific Inc. (US)
Merck KGaA (Germany)
Qiagen N.V. (Germany)
Abbott Laboratories (US)
Biomerieux (France)
Becton, Dickinson and Company (US)
Agilent Technologies, Inc. (US)
Eppendorf AG (Germany)
Bio-Rad Laboratories, Inc. (US)
Takara Bio Inc. (Japan)
Promega Corporation (US)
Meridian Bioscience, Inc. (US)
ENDRESS+HAUSER (Switzerland)
QuidelOrtho Corporation (US)
Lepu Medical Technology Beijing Co Ltd. (China)
Sysmax Corporation (Japan)
Enzo Biochem, Inc. (US)
Biocartis (Belgium)
Stilla Technologies (France)
Antylia Scientific (US)
Bioneer Corporation (South Korea)
Standard BioTools (US)
Seegene Inc. (South Korea)
GenScript (US)
LGC Bioresearch Technologies (England)
Quantabio (US)
Randox Laboratories Ltd. (UK)
New England Biolabs. (US)
PCR Biosystems (UK)

Research Coverage:
This research report categorizes the digital PCR (dPCR) and real-time PCR (qPCR) market by offering ((QPCR product (QPCR Reagents and Consumables, QPCR Instruments), QPCR Software, and QPCR Services) DPCR Product (QPCR Reagents and Consumables, QPCR Instruments (Droplet Digital PCR, Chip Based Digital PCR, and Beaming Digital PCR), DPCR Software, and DPCR Services)), by applications ((QPCR Application (Clinical Application (Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, and Other Clinical Application), Research Application (Single Cell Analysis, Stem Cell Research, Gene Expression, and Other Research Application), Forensic Application, Environmental Applications, and Other Application), and (DPCR Application (Clinical Application (Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, and Other Clinical Application), Research Application (Single Cell Analysis, Stem Cell Research, Gene Expression, and Other Research Application), Forensic Application, Environmental Applications, and Other Application)), by end user ((QPCR End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories, and Others), and (DPCR End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories, and Others)) and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Digital PCR (dPCR) and real-time PCR (qPCR) market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the Digital PCR (dPCR) and real-time PCR (qPCR) market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall digital PCR (dPCR) and real-time PCR (qPCR) market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (Rising incidence and prevalence of target infectious diseases and genetic disorders, Continuous advancements in PCR technologies, The role of PCR in biomarker discovery, Increased use of dPCR and qPCR technologies for point of care (POC) diagnostics), restraints (High device costs associated with dPCR, Technical limitations of qPCR and dPCR, Unfavorable reimbursement scenario for diagnostic companies), opportunities (Growing market penetration in emerging countries, Integration of qPCR and dPCR with Next-Generation Sequencing (NGS), Growing significance of RT-PCR based companion diagnostics in drug development process), and Challenges (Time Consuming methodology involving in sample handling and post-PCR analysis, Lack of accuracy & standardization in protocol, Availability of alternative technologies for disease diagnosis) influencing the growth of the market).
- Product Development/Innovation: Detailed insights on newly launched products of the digital PCR (dPCR) and real-time PCR (qPCR) market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the digital PCR (dPCR) and real-time PCR (qPCR) market
- Competitive Assessment: Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Qiagen N.V. (Germany), Abbott Laboratories (US), Biomerieux (France), Becton, Dickinson and Company (US), Agilent Technologies, Inc. (US), Eppendorf AG (Germany), Bio-Rad Laboratories, Inc. (US), Takara Bio Inc. (Japan), among others in the market.

1 INTRODUCTION 82
1.1 STUDY OBJECTIVES 82
1.2 MARKET DEFINITION 82
1.2.1 INCLUSIONS & EXCLUSIONS 83
1.3 MARKETS COVERED 84
1.3.1 MARKET SEGMENTATION 84
1.3.2 REGIONS COVERED 85
FIGURE 1 REGIONAL SEGMENTATION 85
1.3.3 YEARS CONSIDERED 85
1.3.4 CURRENCY CONSIDERED 86
1.4 STAKEHOLDERS 86
1.5 SUMMARY OF CHANGES 86
1.5.1 RECESSION IMPACT 87
2 RESEARCH METHODOLOGY 88
2.1 RESEARCH APPROACH 88
FIGURE 2 RESEARCH DESIGN METHODOLOGY 88
2.1.1 SECONDARY RESEARCH 89
2.1.2 PRIMARY RESEARCH 89
FIGURE 3 DPCR AND QPCR MARKET: BREAKDOWN OF PRIMARIES 90
2.2 MARKET SIZE ESTIMATION 91
FIGURE 4 DIGITAL PCR (DPCR) AND QUANTITATIVE PCR (QPCR) MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 91
2.2.1 GLOBAL MARKET ESTIMATION 91
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023 92
FIGURE 6 ILLUSTRATIVE EXAMPLE OF QIAGEN N.V.: REVENUE SHARE ANALYSIS (2023) 92
2.2.2 INSIGHTS OF PRIMARY EXPERTS 94
FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 94
2.2.3 SEGMENTAL MARKET SIZE ESTIMATION 95
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 95
2.3 GROWTH RATE PROJECTIONS 96
FIGURE 9 DPCR AND QPCR MARKET: CAGR PROJECTIONS, 2024-2029 96
TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 97
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 97
FIGURE 10 DATA TRIANGULATION METHODOLOGY 98
2.5 STUDY ASSUMPTIONS 98
2.6 RISK ASSESSMENT 99
TABLE 2 RISK ASSESSMENT ANALYSIS 99
2.7 RESEARCH LIMITATIONS 99
2.8 RECESSION IMPACT ANALYSIS 99
3 EXECUTIVE SUMMARY 101
FIGURE 11 QPCR MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION) 101
FIGURE 12 DPCR MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION) 102
FIGURE 13 QPCR MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 103
FIGURE 14 DPCR MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 103
FIGURE 15 QPCR MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 104
FIGURE 16 DPCR MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 104
FIGURE 17 GEOGRAPHIC SNAPSHOT OF DPCR AND QPCR MARKET 105
4 PREMIUM INSIGHTS 106
4.1 DIGITAL PCR (DPCR) AND QUANTITATIVE/REAL-TIME PCR (QPCR) MARKET OVERVIEW 106
FIGURE 18 RISING INCIDENCE OF INFECTIOUS DISEASES AND GENETIC DISORDERS TO DRIVE MARKET DURING FORECAST PERIOD 106
4.2 ASIA PACIFIC: QPCR MARKET, BY OFFERING AND COUNTRY (2024) 107
FIGURE 19 QPCR PRODUCTS SEGMENT IN CHINA TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024 107
4.3 GEOGRAPHIC SNAPSHOT OF DPCR AND QPCR MARKET 108
FIGURE 20 EMERGING MARKETS TO GROW AT HIGHER GROWTH RATE DURING FORECAST PERIOD 108
5 MARKET OVERVIEW 109
5.1 INTRODUCTION 109
5.2 MARKET DYNAMICS 109
FIGURE 21 DPCR AND QPCR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 109
TABLE 3 DPCR AND QPCR MARKET: IMPACT ANALYSIS 110
5.2.1 DRIVERS 111
5.2.1.1 Rising incidence of infectious diseases and genetic disorders 111
TABLE 4 GLOBAL BURDEN OF HIV INFECTIONS, BY REGION (2022) 111
5.2.1.2 Increasing advancements in PCR technologies 112
TABLE 5 CONVENTIONAL PCR VS. QPCR & DPCR 113
5.2.1.3 Increasing applications of PCR in biomarker discovery 113
5.2.1.4 Growing focus on dPCR and qPCR technologies for POC diagnostics 114
5.2.2 RESTRAINTS 114
5.2.2.1 High cost of dPCR instruments 114
5.2.2.2 Technical limitations associated with qPCR and dPCR 115
5.2.2.3 Unfavorable reimbursements for diagnostic companies 115
5.2.3 OPPORTUNITIES 116
5.2.3.1 High growth potential of emerging markets 116
5.2.3.2 Integration of qPCR and dPCR with NGS 116
5.2.3.3 Growing significance of RT-PCR-based companion diagnostics in drug development 117
5.2.4 CHALLENGES 117
5.2.4.1 Time constraints associated with sample handling 117
5.2.4.2 Inadequate protocols for accuracy & standardization 118
5.2.4.3 Availability of alternative technologies 118
5.3 PORTER'S FIVE FORCES ANALYSIS 119
FIGURE 22 DPCR AND QPCR MARKET: PORTER'S FIVE FORCES ANALYSIS 119
TABLE 6 DPCR AND QPCR MARKET: PORTER'S FIVE FORCES ANALYSIS 119
5.3.1 DEGREE OF COMPETITION 120
5.3.2 BARGAINING POWER OF SUPPLIERS 120
5.3.3 BARGAINING POWER OF BUYERS 120
5.3.4 THREAT OF SUBSTITUTES 120
5.3.5 THREAT OF NEW ENTRANTS 120
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 121
FIGURE 23 DPCR AND QPCR MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 121
5.5 TECHNOLOGY ANALYSIS 122
5.5.1 KEY TECHNOLOGIES 122
TABLE 7 KEY TECHNOLOGIES 122
5.5.2 COMPLEMENTARY TECHNOLOGIES 123
TABLE 8 COMPLEMENTARY TECHNOLOGIES 123
5.5.3 ADJACENT TECHNOLOGIES 124
TABLE 9 ADJACENT TECHNOLOGIES 124
5.6 SUPPLY CHAIN ANALYSIS 124
FIGURE 24 SUPPLY CHAIN ANALYSIS 124
5.7 VALUE CHAIN ANALYSIS 125
FIGURE 25 VALUE CHAIN ANALYSIS-MAXIMUM VALUE ADDED DURING RAW MATERIAL PROCUREMENT AND MANUFACTURING STAGES 126
5.8 PRICING ANALYSIS 127
TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT (2023) 127
FIGURE 26 AVERAGE SELLING PRICE TREND FOR QPCR INSTRUMENTS (2021?2023) 128
TABLE 11 AVERAGE SELLING PRICE, BY PRODUCT, BY REGION (2023) 129
5.9 ECOSYSTEM ANALYSIS 129
FIGURE 27 DPCR AND QPCR MARKET: ECOSYSTEM ANALYSIS 129
5.9.1 DPCR AND QPCR MARKET: ROLE OF RAW MATERIAL SUPPLIERS 130
TABLE 12 DPCR AND QPCR MARKET: RAW MATERIAL SUPPLIERS 130
5.9.2 DPCR AND QPCR MARKET: ROLE OF MANUFACTURERS 130
TABLE 13 DPCR AND QPCR MARKET: ROLE OF MANUFACTURERS 131
5.9.3 DPCR AND QPCR MARKET: ROLE OF END USERS 131
TABLE 14 DPCR AND QPCR MARKET: ROLE OF END USERS 132
5.9.4 DPCR AND QPCR MARKET: ROLE OF REGULATORY BODIES 132
TABLE 15 DPCR AND QPCR MARKET: ROLE OF REGULATORY BODIES 132
5.10 PATENT ANALYSIS 133
5.10.1 PATENT METHODOLOGY 133
5.10.2 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024 133
TABLE 16 PATENTS FILED, 2014-2024 133
5.10.3 INNOVATION & PATENT APPLICATIONS 133
FIGURE 28 NUMBER OF PATENTS GRANTED, 2014-2024 133
5.10.4 TOP APPLICANTS 134
FIGURE 29 TOP TEN PATENT APPLICANTS, 2014-2024 134
TABLE 17 TOP 20 PATENT OWNERS IN QPCR AND DPCR MARKET, 2014-2024 134
5.11 KEY CONFERENCES AND EVENTS (2024?2025) 135
TABLE 18 DPCR AND QPCR MARKET: LIST OF CONFERENCES AND EVENTS (2024?2025) 135
5.12 REGULATORY LANDSCAPE 136
5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 136
TABLE 19 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 136
5.12.2 REGULATORY SCENARIO 138
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 141
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 141
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DPCR & QPCR PRODUCTS 141
5.13.2 KEY BUYING CRITERIA AMONG END USERS 142
FIGURE 31 KEY BUYING CRITERIA FOR END USERS 142
TABLE 20 BUYING CRITERIA FOR DPCR AND QPCR PRODUCTS, BY END USER 142
5.14 INVESTMENT & FUNDING SCENARIO 143
5.15 TRADE ANALYSIS 144
TABLE 21 IMPORT VALUE, BY COUNTRY, 2019-2023 (USD THOUSANDS) 144
TABLE 22 EXPORT VALUE, BY COUNTRY, 2019-2023 (USD THOUSAND) 145
TABLE 23 IMPORT VOLUME, BY COUNTRY, 2019-2023 (TONS) 145
TABLE 24 EXPORT VOLUME, BY COUNTRY, 2019-2023 (TONS) 146
6 DPCR AND QPCR MARKET, BY OFFERING 147
6.1 INTRODUCTION 148
TABLE 25 DPCR AND QPCR MARKET, BY OFFERING, 2022-2029 (USD MILLION) 148
6.2 QPCR OFFERINGS 148
TABLE 26 QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 148
TABLE 27 QPCR OFFERING MARKET, BY REGION, 2022-2029 (USD MILLION) 149
TABLE 28 NORTH AMERICA: QPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 149
TABLE 29 EUROPE: QPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 149
TABLE 30 ASIA PACIFIC: QPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 150
TABLE 31 LATIN AMERICA: QPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 150
TABLE 32 MIDDLE EAST: QPCR OFFERINGS MARKET, BY REGION, 2022-2029 (USD MILLION) 150
TABLE 33 GCC COUNTRIES: QPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 151
6.2.1 QPCR PRODUCTS 151
TABLE 34 QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 151
6.2.1.1 qPCR reagents & consumables 151
6.2.1.1.1 Recurring consumption of detection agents to drive market 151
TABLE 35 QPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION) 152
TABLE 36 NORTH AMERICA: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 152
TABLE 37 EUROPE: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 153
TABLE 38 ASIA PACIFIC: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 153
TABLE 39 LATIN AMERICA: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 154
TABLE 40 MIDDLE EAST: QPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION) 154
TABLE 41 GCC COUNTRIES: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 154
TABLE 42 QPCR REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 155
TABLE 43 QPCR REAGENTS & CONSUMABLES MARKET, BY END USER, 2022-2029 (USD MILLION) 155
6.2.1.2 qPCR instruments 156
6.2.1.2.1 Advancements in instrument design to drive market 156
TABLE 44 INSTALLED BASE FOR QPCR INSTRUMENTS, BY PRODUCT, 2019?2023 156
TABLE 45 QPCR INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 156
TABLE 46 NORTH AMERICA: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 157
TABLE 47 EUROPE: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 157
TABLE 48 ASIA PACIFIC: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 157
TABLE 49 LATIN AMERICA: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 158
TABLE 50 MIDDLE EAST: QPCR INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 158
TABLE 51 GCC COUNTRIES: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 158
TABLE 52 QPCR INSTRUMENTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 159
TABLE 53 QPCR INSTRUMENTS MARKET, BY END USER, 2022-2029 (USD MILLION) 159
6.2.2 QPCR SOFTWARE 160
6.2.2.1 Rising demand for specialized analysis software to support market growth 160
TABLE 54 QPCR SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION) 160
TABLE 55 NORTH AMERICA: QPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 160
TABLE 56 EUROPE: QPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 161
TABLE 57 ASIA PACIFIC: QPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 161
TABLE 58 LATIN AMERICA: QPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 161
TABLE 59 MIDDLE EAST: QPCR SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION) 162
TABLE 60 GCC COUNTRIES: QPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 162
TABLE 61 QPCR SOFTWARE MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 162
TABLE 62 QPCR SOFTWARE MARKET, BY END USER, 2022-2029 (USD MILLION) 163
6.2.3 QPCR SERVICES 163
6.2.3.1 Growing requirement for maintenance and calibration of PCR instruments to fuel market 163
TABLE 63 QPCR SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 164
TABLE 64 NORTH AMERICA: QPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 164
TABLE 65 EUROPE: QPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 164
TABLE 66 ASIA PACIFIC: QPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 165
TABLE 67 LATIN AMERICA: QPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 165
TABLE 68 MIDDLE EAST: QPCR SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 165
TABLE 69 GCC COUNTRIES: QPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 166
TABLE 70 QPCR SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 166
TABLE 71 QPCR SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 166
6.3 DPCR OFFERINGS 167
TABLE 72 DPCR OFFERINGS MARKET, BY TYPE, 2022-2029 (USD MILLION) 167
TABLE 73 DPCR OFFERINGS MARKET, BY REGION, 2022-2029 (USD MILLION) 167
TABLE 74 NORTH AMERICA: DPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 168
TABLE 75 EUROPE: DPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 168
TABLE 76 ASIA PACIFIC: DPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 168
TABLE 77 LATIN AMERICA: DPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 169
TABLE 78 MIDDLE EAST: DPCR OFFERINGS MARKET, BY REGION, 2022-2029 (USD MILLION) 169
TABLE 79 GCC COUNTRIES: DPCR OFFERINGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 169
6.3.1 DPCR PRODUCTS 170
TABLE 80 DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 170
6.3.1.1 DPCR reagents & consumables 170
6.3.1.1.1 Availability of novel dPCR reagents to propel market 170
TABLE 81 DPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION) 171
TABLE 82 NORTH AMERICA: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 171
TABLE 83 EUROPE: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 171
TABLE 84 ASIA PACIFIC: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 172
TABLE 85 LATIN AMERICA: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 172
TABLE 86 MIDDLE EAST: DPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION) 172
TABLE 87 GCC COUNTRIES: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 173
TABLE 88 DPCR REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 173
TABLE 89 DPCR REAGENTS & CONSUMABLES MARKET, BY END USER, 2022-2029 (USD MILLION) 174
6.3.1.2 DPCR instruments 174
TABLE 90 DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 174
TABLE 91 DPCR INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 175
TABLE 92 NORTH AMERICA: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 175
TABLE 93 EUROPE: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 175
TABLE 94 ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 176
TABLE 95 LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 176
TABLE 96 MIDDLE EAST: DPCR INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 176
TABLE 97 GCC COUNTRIES: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 177
TABLE 98 DPCR INSTRUMENTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 177
TABLE 99 DPCR INSTRUMENTS MARKET, BY END USER, 2022-2029 (USD MILLION) 178
6.3.1.2.1 Droplet digital PCR 178
6.3.1.2.1.1 High accuracy and time efficiency benefits to fuel uptake 178
TABLE 100 DROPLET DIGITAL PCR MARKET, BY REGION, 2022-2029 (USD MILLION) 178
TABLE 101 NORTH AMERICA: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 179
TABLE 102 EUROPE: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 179
TABLE 103 ASIA PACIFIC: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 179
TABLE 104 LATIN AMERICA: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 180
TABLE 105 MIDDLE EAST: DROPLET DIGITAL PCR MARKET, BY REGION, 2022-2029 (USD MILLION) 180
TABLE 106 GCC COUNTRIES: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 180
6.3.1.2.2 Chip-based digital PCR 181
6.3.1.2.2.1 High-throughput capabilities to boost demand 181
TABLE 107 CHIP-BASED DIGITAL PCR MARKET, BY REGION, 2022-2029 (USD MILLION) 181
TABLE 108 NORTH AMERICA: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 181
TABLE 109 EUROPE: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 182
TABLE 110 ASIA PACIFIC: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 182
TABLE 111 LATIN AMERICA: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 183
TABLE 112 MIDDLE EAST: CHIP-BASED DIGITAL PCR MARKET, BY REGION, 2022-2029 (USD MILLION) 183
TABLE 113 GCC COUNTRIES: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 183
6.3.1.2.3 Beaming digital PCR 184
6.3.1.2.3.1 Growing applications in oncology diagnostics to support market growth 184
TABLE 114 BEAMING DIGITAL PCR MARKET, BY REGION, 2022-2029 (USD MILLION) 184
TABLE 115 NORTH AMERICA: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 184
TABLE 116 EUROPE: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 185
TABLE 117 ASIA PACIFIC: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 185
TABLE 118 LATIN AMERICA: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 185
TABLE 119 MIDDLE EAST: BEAMING DIGITAL PCR MARKET, BY REGION, 2022-2029 (USD MILLION) 186
TABLE 120 GCC COUNTRIES: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 186
6.3.2 DPCR SOFTWARE 186
6.3.2.1 Ability to enhance workflow efficiency to drive market 186
TABLE 121 DPCR SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION) 187
TABLE 122 NORTH AMERICA: DPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 187
TABLE 123 EUROPE: DPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 187
TABLE 124 ASIA PACIFIC: DPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 188
TABLE 125 LATIN AMERICA: DPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 188
TABLE 126 MIDDLE EAST: DPCR SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION) 188
TABLE 127 GCC COUNTRIES: DPCR SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 189
TABLE 128 DPCR SOFTWARE MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 189
TABLE 129 DPCR SOFTWARE MARKET, BY END USER, 2022-2029 (USD MILLION) 190
6.3.3 DPCR SERVICES 190
6.3.3.1 Rising need for application-specific guidance to support market growth 190
TABLE 130 DPCR SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 191
TABLE 131 NORTH AMERICA: DPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 191
TABLE 132 EUROPE: DPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 191
TABLE 133 ASIA PACIFIC: DPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 192
TABLE 134 LATIN AMERICA: DPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 192
TABLE 135 MIDDLE EAST: DPCR SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 192
TABLE 136 GCC COUNTRIES: DPCR SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 193
TABLE 137 DPCR SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 193
TABLE 138 DPCR SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 194
7 DPCR AND QPCR MARKET, BY APPLICATION 195
7.1 INTRODUCTION 196
TABLE 139 QPCR AND DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 196
7.2 QPCR APPLICATIONS 196
TABLE 140 APPLICATION EXAMPLES OF QPCR 196
TABLE 141 QPCR APPLICATIONS MARKET, BY TYPE, 2022-2029 (USD MILLION) 197
7.2.1 CLINICAL APPLICATIONS 197
TABLE 142 QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 143 QPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 198
TABLE 144 NORTH AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 199
TABLE 145 EUROPE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 199
TABLE 146 ASIA PACIFIC: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 200
TABLE 147 LATIN AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 200
TABLE 148 MIDDLE EAST: QPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 201
TABLE 149 GCC COUNTRIES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 201
7.2.1.1 Infectious disease testing 201
7.2.1.1.1 Wide utilization in pathogen testing to fuel market 201
TABLE 150 QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022-2029 (USD MILLION) 202
TABLE 151 NORTH AMERICA: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 202
TABLE 152 EUROPE: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 203
TABLE 153 ASIA PACIFIC: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 203
TABLE 154 LATIN AMERICA: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 204
TABLE 155 MIDDLE EAST: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022-2029 (USD MILLION) 204
TABLE 156 GCC COUNTRIES: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 204
7.2.1.2 Oncology testing 205
7.2.1.2.1 High uptake in tumor screening & classification to boost demand 205
TABLE 157 QPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022-2029 (USD MILLION) 205
TABLE 158 NORTH AMERICA: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 205
TABLE 159 EUROPE: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 206
TABLE 160 ASIA PACIFIC: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 206
TABLE 161 LATIN AMERICA: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 207
TABLE 162 MIDDLE EAST: QPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022-2029 (USD MILLION) 207
TABLE 163 GCC COUNTRIES: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 207
7.2.1.3 Blood screening 208
7.2.1.3.1 Elimination of post-amplification processing to drive market 208
TABLE 164 QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2022-2029 (USD MILLION) 208
TABLE 165 NORTH AMERICA: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION) 208
TABLE 166 EUROPE: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION) 209
TABLE 167 ASIA PACIFIC: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION) 209
TABLE 168 LATIN AMERICA: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION) 210
TABLE 169 MIDDLE EAST: QPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022-2029 (USD MILLION) 210
TABLE 170 GCC COUNTRIES: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION) 210
7.2.1.4 Transplant diagnostics 211
7.2.1.4.1 Growing preference for genome-based products to fuel market 211
TABLE 171 QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION) 211
TABLE 172 NORTH AMERICA: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION) 211
TABLE 173 EUROPE: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION) 212
TABLE 174 ASIA PACIFIC: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION) 212
TABLE 175 LATIN AMERICA: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION) 213
TABLE 176 MIDDLE EAST: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION) 213
TABLE 177 GCC COUNTRIES: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION) 213
7.2.1.5 Other clinical applications 214
TABLE 178 QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 214
TABLE 179 NORTH AMERICA: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 214
TABLE 180 EUROPE: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 215
TABLE 181 ASIA PACIFIC: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 215
TABLE 182 LATIN AMERICA: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 216
TABLE 183 MIDDLE EAST: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 216
TABLE 184 GCC COUNTRIES: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 216
7.2.2 RESEARCH APPLICATIONS 217
TABLE 185 QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 217
TABLE 186 QPCR MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 217
TABLE 187 NORTH AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 218
TABLE 188 EUROPE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 218
TABLE 189 ASIA PACIFIC: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 219
TABLE 190 LATIN AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 219
TABLE 191 MIDDLE EAST: QPCR MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 219
TABLE 192 GCC COUNTRIES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 220
7.2.2.1 Single-cell analysis 220
7.2.2.1.1 Growing need for high-resolution molecular data to drive market 220
TABLE 193 QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022-2029 (USD MILLION) 220
TABLE 194 NORTH AMERICA: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION) 221
TABLE 195 EUROPE: QPCR MARKET FOR SINGLE-CELL ANALYSIS, 2022-2029 (USD MILLION) 221
TABLE 196 ASIA PACIFIC: QPCR MARKET FOR SINGLE-CELL ANALYSIS, 2022-2029 (USD MILLION) 221
TABLE 197 LATIN AMERICA: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION) 222
TABLE 198 MIDDLE EAST: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022-2029 (USD MILLION) 222
TABLE 199 GCC COUNTRIES: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION) 222
7.2.2.2 Stem cell research 223
7.2.2.2.1 Growing focus on regenerative medicine to boost demand 223
TABLE 200 QPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022-2029 (USD MILLION) 223
TABLE 201 NORTH AMERICA: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION) 223
TABLE 202 EUROPE: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION) 224
TABLE 203 ASIA PACIFIC: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION) 224
TABLE 204 LATIN AMERICA: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION) 225
TABLE 205 MIDDLE EAST: QPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022-2029 (USD MILLION) 225
TABLE 206 GCC COUNTRIES: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION) 225
7.2.2.3 Gene expression 226
7.2.2.3.1 Precise quantification requirements to support market growth 226
TABLE 207 QPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022-2029 (USD MILLION) 226
TABLE 208 NORTH AMERICA: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION) 226
TABLE 209 EUROPE: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION) 227
TABLE 210 ASIA PACIFIC: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION) 227
TABLE 211 LATIN AMERICA: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION) 228
TABLE 212 MIDDLE EAST: QPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022-2029 (USD MILLION) 228
TABLE 213 GCC COUNTRIES: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION) 228
7.2.2.4 Other research applications 229
TABLE 214 QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 229
TABLE 215 NORTH AMERICA: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 230
TABLE 216 EUROPE: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 230
TABLE 217 ASIA PACIFIC: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 231
TABLE 218 LATIN AMERICA: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 231
TABLE 219 MIDDLE EAST: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 231
TABLE 220 GCC COUNTRIES: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 232
7.2.3 FORENSIC APPLICATIONS 232
7.2.3.1 Ability to analyze genetic fingerprinting and biological samples to propel market 232
TABLE 221 QPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 232
TABLE 222 NORTH AMERICA: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 233
TABLE 223 EUROPE: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 233
TABLE 224 ASIA PACIFIC: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 234
TABLE 225 LATIN AMERICA: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 234
TABLE 226 MIDDLE EAST: QPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 234
TABLE 227 GCC COUNTRIES: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 235
7.2.4 ENVIRONMENTAL APPLICATIONS 235
7.2.4.1 Development of specialized assays for environmental monitoring to drive market 235
TABLE 228 QPCR ENVIRONMENTAL APPLICATIONS MARKET, BY REGION, 2022-2029 (USD MILLION) 235
TABLE 229 NORTH AMERICA: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 236
TABLE 230 EUROPE: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 236
TABLE 231 ASIA PACIFIC: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 237
TABLE 232 LATIN AMERICA: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 237
TABLE 233 MIDDLE EAST: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 237
TABLE 234 GCC COUNTRIES: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 238
7.2.5 OTHER QPCR APPLICATIONS 238
TABLE 235 OTHER QPCR APPLICATIONS MARKET, BY REGION, 2022-2029 (USD MILLION) 238
TABLE 236 NORTH AMERICA: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 239
TABLE 237 EUROPE: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 239
TABLE 238 ASIA PACIFIC: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 240
TABLE 239 LATIN AMERICA: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 240
TABLE 240 MIDDLE EAST: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 240
TABLE 241 GCC COUNTRIES: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 241
7.3 DPCR APPLICATIONS 241
TABLE 242 DPCR APPLICATIONS MARKET, BY TYPE, 2022-2029 (USD MILLION) 241
7.3.1 CLINICAL APPLICATIONS 242
TABLE 243 DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 242
TABLE 244 DPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 242
TABLE 245 NORTH AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 243
TABLE 246 EUROPE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 243
TABLE 247 ASIA PACIFIC: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 244
TABLE 248 LATIN AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 244
TABLE 249 MIDDLE EAST: DPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 244
TABLE 250 GCC COUNTRIES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 245
7.3.1.1 Infectious disease testing 245
7.3.1.1.1 Accuracy and precision capabilities to boost demand 245
TABLE 251 DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022-2029 (USD MILLION) 245
TABLE 252 NORTH AMERICA: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 246
TABLE 253 EUROPE: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 246
TABLE 254 ASIA PACIFIC: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 247
TABLE 255 LATIN AMERICA: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 247
TABLE 256 MIDDLE EAST: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022-2029 (USD MILLION) 247
TABLE 257 GCC COUNTRIES: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 248
7.3.1.2 Oncology testing 248
7.3.1.2.1 Detection and monitoring of cancer-related genetic alterations to drive market 248
TABLE 258 DPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022-2029 (USD MILLION) 249
TABLE 259 NORTH AMERICA: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 249
TABLE 260 EUROPE: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 249
TABLE 261 ASIA PACIFIC: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 250
TABLE 262 LATIN AMERICA: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 250
TABLE 263 MIDDLE EAST: DPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022-2029 (USD MILLION) 250
TABLE 264 GCC COUNTRIES: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022-2029 (USD MILLION) 251
7.3.1.3 Blood screening 251
7.3.1.3.1 Highly sensitive detection of infectious agents to support market growth 251
TABLE 265 DPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022-2029 (USD MILLION) 251
TABLE 266 NORTH AMERICA: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION) 252
TABLE 267 EUROPE: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION) 252
TABLE 268 ASIA PACIFIC: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION) 253
TABLE 269 LATIN AMERICA: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION) 253
TABLE 270 MIDDLE EAST: DPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022-2029 (USD MILLION) 253
TABLE 271 GCC COUNTRIES: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022-2029 (USD MILLION) 254

7.3.1.4 Transplant diagnostics 254
7.3.1.4.1 Low market availability to restrain market 254
TABLE 272 DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION) 254
TABLE 273 NORTH AMERICA: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION) 255
TABLE 274 EUROPE: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION) 255
TABLE 275 ASIA PACIFIC: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION) 256
TABLE 276 LATIN AMERICA: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION) 256
TABLE 277 MIDDLE EAST: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION) 256
TABLE 278 GCC COUNTRIES: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION) 257
7.3.1.5 Other clinical applications 257
TABLE 279 DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 257
TABLE 280 NORTH AMERICA: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 258
TABLE 281 EUROPE: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 258
TABLE 282 ASIA PACIFIC: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 259
TABLE 283 LATIN AMERICA: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 259
TABLE 284 MIDDLE EAST: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 259
TABLE 285 GCC COUNTRIES: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 260
7.3.2 RESEARCH APPLICATIONS 260
7.3.2.1 High uptake by pharma & biotech companies for drug screening to drive market 260
TABLE 286 DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 260
7.3.2.2 Single-cell analysis 261
7.3.2.2.1 dDPCR compatibility with one-step RT-PCR to boost demand 261
TABLE 287 DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022-2029 (USD MILLION) 261
TABLE 288 NORTH AMERICA: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION) 262
TABLE 289 EUROPE: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION) 262
TABLE 290 ASIA PACIFIC: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION) 263
TABLE 291 LATIN AMERICA: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION) 263
TABLE 292 MIDDLE EAST: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022-2029 (USD MILLION) 263
TABLE 293 GCC COUNTRIES: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022-2029 (USD MILLION) 264
7.3.2.3 Stem cell research 264
7.3.2.3.1 Growing need for reliable tools to assess stem cell quality & potency to boost demand 264
TABLE 294 DPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022-2029 (USD MILLION) 264
TABLE 295 NORTH AMERICA: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION) 265
TABLE 296 EUROPE: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION) 265
TABLE 297 ASIA PACIFIC: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION) 266
TABLE 298 LATIN AMERICA: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION) 266
TABLE 299 MIDDLE EAST: DPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022-2029 (USD MILLION) 267
TABLE 300 GCC COUNTRIES: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION) 267
7.3.2.4 Gene expression 267
7.3.2.4.1 Increasing demand for accurate quantification methods in personalized medicine to drive market 267
TABLE 301 DPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022-2029 (USD MILLION) 268
TABLE 302 NORTH AMERICA: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION) 268
TABLE 303 EUROPE: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION) 269
TABLE 304 ASIA PACIFIC: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION) 269
TABLE 305 LATIN AMERICA: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION) 270
TABLE 306 MIDDLE EAST: DPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022-2029 (USD MILLION) 270
TABLE 307 GCC COUNTRIES: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022-2029 (USD MILLION) 270
7.3.2.5 Other research applications 271
TABLE 308 DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 271
TABLE 309 NORTH AMERICA: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 272
TABLE 310 EUROPE: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 272
TABLE 311 ASIA PACIFIC: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 273
TABLE 312 LATIN AMERICA: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 273
TABLE 313 MIDDLE EAST: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 273
TABLE 314 GCC COUNTRIES: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 274
7.3.3 FORENSIC APPLICATIONS 274
7.3.3.1 DNA profiling benefits to support market growth 274
TABLE 315 DPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 275
TABLE 316 NORTH AMERICA: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 275
TABLE 317 EUROPE: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 275
TABLE 318 ASIA PACIFIC: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 276
TABLE 319 LATIN AMERICA: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 276
TABLE 320 MIDDLE EAST: DPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 276
TABLE 321 GCC COUNTRIES: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 277
7.3.4 ENVIRONMENTAL APPLICATIONS 277
7.3.4.1 Increasing demand for wastewater surveillance to drive market 277
TABLE 322 DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 277
TABLE 323 NORTH AMERICA: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 278
TABLE 324 EUROPE: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 278
TABLE 325 ASIA PACIFIC: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 279
TABLE 326 LATIN AMERICA: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 279
TABLE 327 MIDDLE EAST: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 279
TABLE 328 GCC COUNTRIES: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 280
7.3.5 OTHER DPCR APPLICATIONS 280
TABLE 329 OTHER DPCR APPLICATIONS MARKET, BY REGION, 2022-2029 (USD MILLION) 280
TABLE 330 NORTH AMERICA: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 281
TABLE 331 EUROPE: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 281
TABLE 332 ASIA PACIFIC: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 282
TABLE 333 LATIN AMERICA: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 282
TABLE 334 MIDDLE EAST: OTHER DPCR APPLICATIONS MARKET, BY REGION, 2022-2029 (USD MILLION) 282
TABLE 335 GCC COUNTRIES: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 283
8 DPCR AND QPCR MARKET, BY END USER 284
8.1 INTRODUCTION 285
TABLE 336 DPCR AND QPCR MARKET FOR END USERS, BY TECHNOLOGY, 2022-2029 (USD MILLION) 285
8.2 QPCR END USERS 285
TABLE 337 QPCR MARKET FOR END USERS, BY TYPE, 2022-2029 (USD MILLION) 285
8.2.1 HOSPITALS AND DIAGNOSTIC LABORATORIES 286
8.2.1.1 Growing uptake in disease diagnostics to drive market 286
TABLE 338 QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION) 286
TABLE 339 NORTH AMERICA: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 286
TABLE 340 EUROPE: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 287
TABLE 341 ASIA PACIFIC: QPCR FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 287
TABLE 342 LATIN AMERICA: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 288
TABLE 343 MIDDLE EAST: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION) 288
TABLE 344 GCC COUNTRIES: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 288
8.2.2 ACADEMIC & RESEARCH INSTITUTES 289
8.2.2.1 Growing focus on genetic & molecular studies to boost demand 289
TABLE 345 QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION) 289
TABLE 346 NORTH AMERICA: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 289
TABLE 347 EUROPE: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 290
TABLE 348 ASIA PACIFIC: QPCR FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 290
TABLE 349 LATIN AMERICA: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 291
TABLE 350 MIDDLE EAST: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION) 291
TABLE 351 GCC COUNTRIES: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 291
8.2.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 292
8.2.3.1 Rising focus on drug discovery & development to propel market 292
TABLE 352 QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION) 292
TABLE 353 NORTH AMERICA: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 292
TABLE 354 EUROPE: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 293
TABLE 355 ASIA PACIFIC: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 293
TABLE 356 LATIN AMERICA: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 294
TABLE 357 MIDDLE EAST: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION) 294
TABLE 358 GCC COUNTRIES: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 294
8.2.4 CROS AND CDMOS 295
8.2.4.1 Increasing outsourcing of drug development activities by pharma companies to boost demand 295
TABLE 359 QPCR MARKET FOR CROS AND CDMOS, BY REGION, 2022-2029 (USD MILLION) 295
TABLE 360 NORTH AMERICA: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 295
TABLE 361 EUROPE: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 296
TABLE 362 ASIA PACIFIC: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 296
TABLE 363 LATIN AMERICA: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 297
TABLE 364 MIDDLE EAST: QPCR MARKET FOR CROS AND CDMOS, BY REGION, 2022-2029 (USD MILLION) 297
TABLE 365 GCC COUNTRIES: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 297
8.2.5 FORENSIC LABORATORIES 298
8.2.5.1 Growing trend of laboratory automation to drive market 298
TABLE 366 QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION) 298
TABLE 367 NORTH AMERICA: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 298
TABLE 368 EUROPE: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 299
TABLE 369 ASIA PACIFIC: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 299
TABLE 370 LATIN AMERICA: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 300
TABLE 371 MIDDLE EAST: QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION) 300
TABLE 372 GCC COUNTRIES: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 300
8.2.6 OTHER END USERS 301
TABLE 373 QPCR MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION) 301
TABLE 374 NORTH AMERICA: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION) 301
TABLE 375 EUROPE: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION) 302
TABLE 376 ASIA PACIFIC: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION) 302
TABLE 377 LATIN AMERICA: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION) 303
TABLE 378 MIDDLE EAST: QPCR MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION) 303
TABLE 379 GCC COUNTRIES: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION) 303
8.3 DPCR END USERS 304
TABLE 380 DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 304
8.3.1 HOSPITALS AND DIAGNOSTIC LABORATORIES 304
8.3.1.1 High uptake in genetic testing and embryo DNA profiling to drive market 304
TABLE 381 DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION) 305
TABLE 382 NORTH AMERICA: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 305
TABLE 383 EUROPE: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, 2022-2029 (USD MILLION) 305
TABLE 384 ASIA PACIFIC: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 306
TABLE 385 LATIN AMERICA: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 306
TABLE 386 MIDDLE EAST: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION) 306
TABLE 387 GCC COUNTRIES: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 307
8.3.2 ACADEMIC & RESEARCH INSTITUTES 307
8.3.2.1 Rising R&D funding investments to support market growth 307
TABLE 388 DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION) 307
TABLE 389 NORTH AMERICA: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 308
TABLE 390 EUROPE: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, 2022-2029 (USD MILLION) 308
TABLE 391 ASIA PACIFIC: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 309
TABLE 392 LATIN AMERICA: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 309
TABLE 393 MIDDLE EAST: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION) 309
TABLE 394 GCC COUNTRIES: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 310
8.3.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 310
8.3.3.1 High uptake in toxicity & clinical studies to drive market 310
TABLE 395 DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION) 311
TABLE 396 NORTH AMERICA: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 311
TABLE 397 EUROPE: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 311
TABLE 398 ASIA PACIFIC: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 312
TABLE 399 LATIN AMERICA: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 312
TABLE 400 MIDDLE EAST: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION) 312
TABLE 401 GCC COUNTRIES: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 313
8.3.4 CROS AND CDMOS 313
8.3.4.1 Rising number of clinical trials to support market growth 313
TABLE 402 DPCR MARKET FOR CROS AND CDMOS, BY REGION, 2022-2029 (USD MILLION) 313
TABLE 403 NORTH AMERICA: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 314
TABLE 404 EUROPE: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 314
TABLE 405 ASIA PACIFIC: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 315
TABLE 406 LATIN AMERICA: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 315
TABLE 407 MIDDLE EAST: DPCR MARKET FOR CROS AND CDMOS, BY REGION, 2022-2029 (USD MILLION) 315
TABLE 408 GCC COUNTRIES: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) 316
8.3.5 FORENSIC LABORATORIES 316
8.3.5.1 Development of advanced dPCR assays to support market growth 316
TABLE 409 DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION) 316
TABLE 410 NORTH AMERICA: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 317
TABLE 411 EUROPE: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 317
TABLE 412 ASIA PACIFIC: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 318
TABLE 413 LATIN AMERICA: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 318
TABLE 414 MIDDLE EAST: DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION) 318
TABLE 415 GCC COUNTRIES: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 319
8.3.6 OTHER END USERS 319
TABLE 416 DPCR MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION) 319
TABLE 417 NORTH AMERICA: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION) 320
TABLE 418 EUROPE: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION) 320
TABLE 419 ASIA PACIFIC: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION) 321
TABLE 420 LATIN AMERICA: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION) 321
TABLE 421 MIDDLE EAST: DPCR MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION) 321
TABLE 422 GCC COUNTRIES: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION) 322
9 DPCR AND QPCR MARKET, BY REGION 323
9.1 INTRODUCTION 324
TABLE 423 DPCR AND QPCR MARKET, BY REGION, 2022-2029 (USD MILLION) 324
9.2 NORTH AMERICA 324
9.2.1 NORTH AMERICA: RECESSION IMPACT 325
FIGURE 32 NORTH AMERICA: DPCR AND QPCR MARKET SNAPSHOT 326
TABLE 424 NORTH AMERICA: DPCR AND QPCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 326
TABLE 425 NORTH AMERICA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 327
TABLE 426 NORTH AMERICA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 327
TABLE 427 NORTH AMERICA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 327
TABLE 428 NORTH AMERICA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 328
TABLE 429 NORTH AMERICA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 328
TABLE 430 NORTH AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 328
TABLE 431 NORTH AMERICA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 329
TABLE 432 NORTH AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 329
TABLE 433 NORTH AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 330
TABLE 434 NORTH AMERICA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 330
TABLE 435 NORTH AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 331
TABLE 436 NORTH AMERICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 331
TABLE 437 NORTH AMERICA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 332
TABLE 438 NORTH AMERICA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 332
9.2.2 US 333
9.2.2.1 Rising adoption of advanced technologies to drive market 333
TABLE 439 US: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 333
TABLE 440 US: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 333
TABLE 441 US: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 334
TABLE 442 US: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 334
TABLE 443 US: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 334
TABLE 444 US: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 335
TABLE 445 US: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 335
TABLE 446 US: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 335
TABLE 447 US: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 336
TABLE 448 US: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 336
TABLE 449 US: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 336
TABLE 450 US: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 337
TABLE 451 US: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 337
TABLE 452 US: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 338
9.2.3 CANADA 338
9.2.3.1 Supportive government initiatives for genomics research to drive market 338
TABLE 453 CANADA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 339
TABLE 454 CANADA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 339
TABLE 455 CANADA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 339
TABLE 456 CANADA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 340
TABLE 457 CANADA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 340
TABLE 458 CANADA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 340
TABLE 459 CANADA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 341
TABLE 460 CANADA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 341
TABLE 461 CANADA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 342
TABLE 462 CANADA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 342
TABLE 463 CANADA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 343
TABLE 464 CANADA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 343
TABLE 465 CANADA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 344
TABLE 466 CANADA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 344
9.3 EUROPE 345
9.3.1 EUROPE: RECESSION IMPACT 345
TABLE 467 EUROPE: QPCR AND DPCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 346
TABLE 468 EUROPE: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 346
TABLE 469 EUROPE: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 346
TABLE 470 EUROPE: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 347
TABLE 471 EUROPE: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 347
TABLE 472 EUROPE: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 347
TABLE 473 EUROPE: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 348
TABLE 474 EUROPE: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 348
TABLE 475 EUROPE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 349
TABLE 476 EUROPE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 349
TABLE 477 EUROPE: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 350
TABLE 478 EUROPE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 350
TABLE 479 EUROPE: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 351
TABLE 480 EUROPE: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 351
TABLE 481 EUROPE: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 352
9.3.2 GERMANY 352
9.3.2.1 Rising healthcare expenditure and favorable reimbursements for diagnostic procedures to boost demand 352
TABLE 482 GERMANY: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 353
TABLE 483 GERMANY: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 353
TABLE 484 GERMANY: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 353
TABLE 485 GERMANY: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 354
TABLE 486 GERMANY: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 354
TABLE 487 GERMANY: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 354
TABLE 488 GERMANY: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 355
TABLE 489 GERMANY: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 355
TABLE 490 GERMANY: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 356
TABLE 491 GERMANY: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 356
TABLE 492 GERMANY: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 357
TABLE 493 GERMANY: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 357
TABLE 494 GERMANY: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 358
TABLE 495 GERMANY: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 358
9.3.3 UK 359
9.3.3.1 Growing focus on genomics research to drive market 359
TABLE 496 UK: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 359
TABLE 497 UK: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 359
TABLE 498 UK: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 360
TABLE 499 UK: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 360
TABLE 500 UK: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 360
TABLE 501 UK: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 361
TABLE 502 UK: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 361
TABLE 503 UK: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 361
TABLE 504 UK: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 362
TABLE 505 UK: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 362
TABLE 506 UK: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 362
TABLE 507 UK: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 363
TABLE 508 UK: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 363
TABLE 509 UK: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 364
9.3.4 FRANCE 364
9.3.4.1 Supportive government regulations for diagnostic assay procedures to drive market 364
TABLE 510 FRANCE: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 364
TABLE 511 FRANCE: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 365
TABLE 512 FRANCE: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 365
TABLE 513 FRANCE: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 365
TABLE 514 FRANCE: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 366
TABLE 515 FRANCE: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 366
TABLE 516 FRANCE: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 366
TABLE 517 FRANCE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 367
TABLE 518 FRANCE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 367
TABLE 519 FRANCE: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 368
TABLE 520 FRANCE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 368
TABLE 521 FRANCE: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 369
TABLE 522 FRANCE: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 369
TABLE 523 FRANCE: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 370
9.3.5 ITALY 370
9.3.5.1 Increasing funding investments for development of innovative therapies to fuel market 370
TABLE 524 ITALY: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 371
TABLE 525 ITALY: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 371
TABLE 526 ITALY: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 371
TABLE 527 ITALY: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 372
TABLE 528 ITALY: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 372
TABLE 529 ITALY: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 372
TABLE 530 ITALY: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 373
TABLE 531 ITALY: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 373
TABLE 532 ITALY: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 374
TABLE 533 ITALY: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 374
TABLE 534 ITALY: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 375
TABLE 535 ITALY: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 375
TABLE 536 ITALY: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 376
TABLE 537 ITALY: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 376
9.3.6 SPAIN 377
9.3.6.1 Rising funding investments for R&D to support market growth 377
TABLE 538 SPAIN: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 377
TABLE 539 SPAIN: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 377
TABLE 540 SPAIN: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 378
TABLE 541 SPAIN: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 378
TABLE 542 SPAIN: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 378
TABLE 543 SPAIN: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 379
TABLE 544 SPAIN: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 379
TABLE 545 SPAIN: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 380
TABLE 546 SPAIN: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 380
TABLE 547 SPAIN: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 381
TABLE 548 SPAIN: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 381
TABLE 549 SPAIN: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 382
TABLE 550 SPAIN: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 382
TABLE 551 SPAIN: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 383
9.3.7 REST OF EUROPE 383
TABLE 552 REST OF EUROPE: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 383
TABLE 553 REST OF EUROPE: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 384
TABLE 554 REST OF EUROPE: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 384
TABLE 555 REST OF EUROPE: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 384
TABLE 556 REST OF EUROPE: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 385
TABLE 557 REST OF EUROPE: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 385
TABLE 558 REST OF EUROPE: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 385
TABLE 559 REST OF EUROPE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 386
TABLE 560 REST OF EUROPE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 386
TABLE 561 REST OF EUROPE: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 387
TABLE 562 REST OF EUROPE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 387
TABLE 563 REST OF EUROPE: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 388
TABLE 564 REST OF EUROPE: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 388
TABLE 565 REST OF EUROPE: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 389
9.4 ASIA PACIFIC 389
9.4.1 ASIA PACIFIC: RECESSION IMPACT 389
FIGURE 33 ASIA PACIFIC: DPCR & QPCR MARKET SNAPSHOT 390
TABLE 566 ASIA PACIFIC: QPCR AND DPCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 391
TABLE 567 ASIA PACIFIC: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 391
TABLE 568 ASIA PACIFIC: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 391
TABLE 569 ASIA PACIFIC: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 392
TABLE 570 ASIA PACIFIC: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 392
TABLE 571 ASIA PACIFIC: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 392
TABLE 572 ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 393
TABLE 573 ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 393
TABLE 574 ASIA PACIFIC: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 393
TABLE 575 ASIA PACIFIC: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 394
TABLE 576 ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 394
TABLE 577 ASIA PACIFIC: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 395
TABLE 578 ASIA PACIFIC: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 395
TABLE 579 ASIA PACIFIC: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 396
TABLE 580 ASIA PACIFIC: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 396

9.4.2 CHINA 397
9.4.2.1 Modernization of healthcare infrastructure to propel market 397
TABLE 581 CHINA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 398
TABLE 582 CHINA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 398
TABLE 583 CHINA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 398
TABLE 584 CHINA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 399
TABLE 585 CHINA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 399
TABLE 586 CHINA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 399
TABLE 587 CHINA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 400
TABLE 588 CHINA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 400
TABLE 589 CHINA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 401
TABLE 590 CHINA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 401
TABLE 591 CHINA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 402
TABLE 592 CHINA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 402
TABLE 593 CHINA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 403
TABLE 594 CHINA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 403
9.4.3 JAPAN 404
9.4.3.1 Rising number of oncology research activities to drive market 404
TABLE 595 JAPAN: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 404
TABLE 596 JAPAN: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 405
TABLE 597 JAPAN: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 405
TABLE 598 JAPAN: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 405
TABLE 599 JAPAN: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 406
TABLE 600 JAPAN: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 406
TABLE 601 JAPAN: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 406
TABLE 602 JAPAN: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 407
TABLE 603 JAPAN: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 407
TABLE 604 JAPAN: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 408
TABLE 605 JAPAN: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 408
TABLE 606 JAPAN: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 409
TABLE 607 JAPAN: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 409
TABLE 608 JAPAN: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 410
9.4.4 INDIA 410
9.4.4.1 Growth in pharmaceutical industry to drive market 410
TABLE 609 INDIA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 411
TABLE 610 INDIA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 411
TABLE 611 INDIA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 411
TABLE 612 INDIA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 411
TABLE 613 INDIA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 412
TABLE 614 INDIA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 412
TABLE 615 INDIA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 412
TABLE 616 INDIA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 413
TABLE 617 INDIA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 413
TABLE 618 INDIA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 414
TABLE 619 INDIA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 414
TABLE 620 INDIA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 415
TABLE 621 INDIA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 415
TABLE 622 INDIA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 416
9.4.5 AUSTRALIA 416
9.4.5.1 Growth in biopharmaceuticals market sector to fuel market 416
TABLE 623 AUSTRALIA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 416
TABLE 624 AUSTRALIA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 417
TABLE 625 AUSTRALIA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 417
TABLE 626 AUSTRALIA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 417
TABLE 627 AUSTRALIA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 418
TABLE 628 AUSTRALIA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 418
TABLE 629 AUSTRALIA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 418
TABLE 630 AUSTRALIA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 419
TABLE 631 AUSTRALIA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 419
TABLE 632 AUSTRALIA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 419
TABLE 633 AUSTRALIA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 420
TABLE 634 AUSTRALIA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 420
TABLE 635 AUSTRALIA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 421
TABLE 636 AUSTRALIA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 421
9.4.6 SOUTH KOREA 422
9.4.6.1 Development of advanced PCR-based diagnostic instruments to support market growth 422
TABLE 637 SOUTH KOREA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 422
TABLE 638 SOUTH KOREA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 422
TABLE 639 SOUTH KOREA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 423
TABLE 640 SOUTH KOREA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 423
TABLE 641 SOUTH KOREA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 423
TABLE 642 SOUTH KOREA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 424
TABLE 643 SOUTH KOREA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 424
TABLE 644 SOUTH KOREA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 424
TABLE 645 SOUTH KOREA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 425
TABLE 646 SOUTH KOREA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 425
TABLE 647 SOUTH KOREA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 426
TABLE 648 SOUTH KOREA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 426
TABLE 649 SOUTH KOREA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 427
TABLE 650 SOUTH KOREA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 427
9.4.7 REST OF ASIA PACIFIC 428
TABLE 651 REST OF ASIA PACIFIC: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 428
TABLE 652 REST OF ASIA PACIFIC: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 428
TABLE 653 REST OF ASIA PACIFIC: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 428
TABLE 654 REST OF ASIA PACIFIC: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 429
TABLE 655 REST OF ASIA PACIFIC: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 429
TABLE 656 REST OF ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 429
TABLE 657 REST OF ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 430
TABLE 658 REST OF ASIA PACIFIC: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 430
TABLE 659 REST OF ASIA PACIFIC: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 431
TABLE 660 REST OF ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 431
TABLE 661 REST OF ASIA PACIFIC: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 432
TABLE 662 REST OF ASIA PACIFIC: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 432
TABLE 663 REST OF ASIA PACIFIC: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 433
TABLE 664 REST OF ASIA PACIFIC: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 433
9.5 LATIN AMERICA 434
9.5.1 LATIN AMERICA: RECESSION IMPACT 434
TABLE 665 LATIN AMERICA: QPCR AND DPCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 434
TABLE 666 LATIN AMERICA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 435
TABLE 667 LATIN AMERICA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 435
TABLE 668 LATIN AMERICA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 435
TABLE 669 LATIN AMERICA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 436
TABLE 670 LATIN AMERICA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 436
TABLE 671 LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 436
TABLE 672 LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 437
TABLE 673 LATIN AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 437
TABLE 674 LATIN AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 438
TABLE 675 LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 438
TABLE 676 LATIN AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 439
TABLE 677 LATIN AMERICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 439
TABLE 678 LATIN AMERICA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 440
TABLE 679 LATIN AMERICA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 440
9.5.2 BRAZIL 441
9.5.2.1 High burden of chronic and infectious diseases to propel market 441
TABLE 680 BRAZIL: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 441
TABLE 681 BRAZIL: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 441
TABLE 682 BRAZIL: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 442
TABLE 683 BRAZIL: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 442
TABLE 684 BRAZIL: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 442
TABLE 685 BRAZIL: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 443
TABLE 686 BRAZIL: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 443
TABLE 687 BRAZIL: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 443
TABLE 688 BRAZIL: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 444
TABLE 689 BRAZIL: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 444
TABLE 690 BRAZIL: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 444
TABLE 691 BRAZIL: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 445
TABLE 692 BRAZIL: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 445
TABLE 693 BRAZIL: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 446
9.5.3 MEXICO 446
9.5.3.1 Growing availability of advanced diagnostic instruments to boost demand 446
TABLE 694 MEXICO: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 447
TABLE 695 MEXICO: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 447
TABLE 696 MEXICO: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 447
TABLE 697 MEXICO: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 448
TABLE 698 MEXICO: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 448
TABLE 699 MEXICO: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 448
TABLE 700 MEXICO: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 449
TABLE 701 MEXICO: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 449
TABLE 702 MEXICO: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 450
TABLE 703 MEXICO: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 450
TABLE 704 MEXICO: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 451
TABLE 705 MEXICO: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 451
TABLE 706 MEXICO: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 452
TABLE 707 MEXICO: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 452
9.5.4 REST OF LATIN AMERICA 452
TABLE 708 REST OF LATIN AMERICA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 453
TABLE 709 REST OF LATIN AMERICA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 453
TABLE 710 REST OF LATIN AMERICA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 453
TABLE 711 REST OF LATIN AMERICA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 454
TABLE 712 REST OF LATIN AMERICA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 454
TABLE 713 REST OF LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 454
TABLE 714 REST OF LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 455
TABLE 715 REST OF LATIN AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 455
TABLE 716 REST OF LATIN AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 456
TABLE 717 REST OF LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 456
TABLE 718 REST OF LATIN AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 457
TABLE 719 REST OF LATIN AMERICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 457
TABLE 720 REST OF LATIN AMERICA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 458
TABLE 721 REST OF LATIN AMERICA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 458
9.6 MIDDLE EAST 459
9.6.1 MIDDLE EAST: RECESSION IMPACT 459
TABLE 722 MIDDLE EAST: DPCR AND QPCR MARKET, BY REGION, 2022-2029 (USD MILLION) 459
TABLE 723 MIDDLE EAST: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 460
TABLE 724 MIDDLE EAST: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 460
TABLE 725 MIDDLE EAST: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 460
TABLE 726 MIDDLE EAST: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 461
TABLE 727 MIDDLE EAST: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 461
TABLE 728 MIDDLE EAST: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 461
TABLE 729 MIDDLE EAST: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 462
TABLE 730 MIDDLE EAST: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 462
TABLE 731 MIDDLE EAST: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 463
TABLE 732 MIDDLE EAST: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 463
TABLE 733 MIDDLE EAST: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 464
TABLE 734 MIDDLE EAST: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 464
TABLE 735 MIDDLE EAST: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 465
TABLE 736 MIDDLE EAST: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 465
9.6.2 GCC COUNTRIES 465
TABLE 737 GCC COUNTRIES: DPCR AND QPCR MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 466
TABLE 738 GCC COUNTRIES: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 466
TABLE 739 GCC COUNTRIES: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 466
TABLE 740 GCC COUNTRIES: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 467
TABLE 741 GCC COUNTRIES: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 467
TABLE 742 GCC COUNTRIES: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 467
TABLE 743 GCC COUNTRIES: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 468
TABLE 744 GCC COUNTRIES: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 468
TABLE 745 GCC COUNTRIES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 469
TABLE 746 GCC COUNTRIES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 469
TABLE 747 GCC COUNTRIES: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 470
TABLE 748 GCC COUNTRIES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 470
TABLE 749 GCC COUNTRIES: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 471
TABLE 750 GCC COUNTRIES: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 471
TABLE 751 GCC COUNTRIES: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 472
9.6.2.1 Kingdom of Saudi Arabia 472
9.6.2.1.1 Growing healthcare expenditure to boost market 472
TABLE 752 KINGDOM OF SAUDI ARABIA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 473
TABLE 753 KINGDOM OF SAUDI ARABIA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 473
TABLE 754 KINGDOM OF SAUDI ARABIA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 473
TABLE 755 KINGDOM OF SAUDI ARABIA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 474
TABLE 756 KINGDOM OF SAUDI ARABIA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 474
TABLE 757 KINGDOM OF SAUDI ARABIA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 474
TABLE 758 KINGDOM OF SAUDI ARABIA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 475
TABLE 759 KINGDOM OF SAUDI ARABIA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 475
TABLE 760 KINGDOM OF SAUDI ARABIA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 476
TABLE 761 KINGDOM OF SAUDI ARABIA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 476
TABLE 762 KINGDOM OF SAUDI ARABIA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 477
TABLE 763 KINGDOM OF SAUDI ARABIA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 477
TABLE 764 KINGDOM OF SAUDI ARABIA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 478
TABLE 765 KINGDOM OF SAUDI ARABIA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 478
9.6.2.2 United Arab Emirates 479
9.6.2.2.1 High production of biopharmaceuticals to support market growth 479
TABLE 766 UNITED ARAB EMIRATES: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 479
TABLE 767 UNITED ARAB EMIRATES: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 479
TABLE 768 UNITED ARAB EMIRATES: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 480
TABLE 769 UNITED ARAB EMIRATES: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 480
TABLE 770 UNITED ARAB EMIRATES: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 480
TABLE 771 UNITED ARAB EMIRATES: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 481
TABLE 772 UNITED ARAB EMIRATES: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 481
TABLE 773 UNITED ARAB EMIRATES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 481
TABLE 774 UNITED ARAB EMIRATES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 482
TABLE 775 UNITED ARAB EMIRATES: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 482
TABLE 776 UNITED ARAB EMIRATES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 483
TABLE 777 UNITED ARAB EMIRATES: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 483
TABLE 778 UNITED ARAB EMIRATES: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 484
TABLE 779 UNITED ARAB EMIRATES: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 484
9.6.2.3 Other GCC Countries 485
TABLE 780 OTHER GCC COUNTRIES: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 485
TABLE 781 OTHER GCC COUNTRIES: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 485
TABLE 782 OTHER GCC COUNTRIES: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 485
TABLE 783 OTHER GCC COUNTRIES: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 486
TABLE 784 OTHER GCC COUNTRIES: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 486
TABLE 785 OTHER GCC COUNTRIES: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 486
TABLE 786 OTHER GCC COUNTRIES: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 487
TABLE 787 OTHER GCC COUNTRIES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 487
TABLE 788 OTHER GCC COUNTRIES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 488
TABLE 789 OTHER GCC COUNTRIES: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 488
TABLE 790 OTHER GCC COUNTRIES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 489
TABLE 791 OTHER GCC COUNTRIES: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 489
TABLE 792 OTHER GCC COUNTRIES: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 490
TABLE 793 OTHER GCC COUNTRIES: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 490
9.6.3 REST OF MIDDLE EAST 491
TABLE 794 REST OF MIDDLE EAST: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 491
TABLE 795 REST OF MIDDLE EAST: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 491
TABLE 796 REST OF MIDDLE EAST: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 491
TABLE 797 REST OF MIDDLE EAST: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 492
TABLE 798 REST OF MIDDLE EAST: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 492
TABLE 799 REST OF MIDDLE EAST: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 492
TABLE 800 REST OF MIDDLE EAST: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 493
TABLE 801 REST OF MIDDLE EAST: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 493
TABLE 802 REST OF MIDDLE EAST: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 494
TABLE 803 REST OF MIDDLE EAST: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 494
TABLE 804 REST OF MIDDLE EAST: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 495
TABLE 805 REST OF MIDDLE EAST: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 495
TABLE 806 REST OF MIDDLE EAST: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 496
TABLE 807 REST OF MIDDLE EAST: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 496
9.7 AFRICA 497
9.7.1 INCREASING FOCUS ON CANCER DIAGNOSTICS TO SUPPORT MARKET GROWTH 497
9.7.2 AFRICA: RECESSION IMPACT 497
TABLE 808 AFRICA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 497
TABLE 809 AFRICA: QPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 498
TABLE 810 AFRICA: QPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 498
TABLE 811 AFRICA: DPCR OFFERING MARKET, BY TYPE, 2022-2029 (USD MILLION) 498
TABLE 812 AFRICA: DPCR PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 499
TABLE 813 AFRICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 499
TABLE 814 AFRICA: QPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 499
TABLE 815 AFRICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 500
TABLE 816 AFRICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 500
TABLE 817 AFRICA: DPCR MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 501
TABLE 818 AFRICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 501
TABLE 819 AFRICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 502
TABLE 820 AFRICA: QPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 502
TABLE 821 AFRICA: DPCR MARKET, BY END USER, 2022-2029 (USD MILLION) 503
10 COMPETITIVE LANDSCAPE 504
10.1 INTRODUCTION 504
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 504
TABLE 822 DPCR AND QPCR MARKET: STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES 504
10.3 REVENUE ANALYSIS 505
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS, 2019?2023 (USD MILLION) 506
10.4 MARKET SHARE ANALYSIS 506
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023) 507
TABLE 823 DPCR AND QPCR MARKET: DEGREE OF COMPETITION 507
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 508
10.5.1 STARS 508
10.5.2 EMERGING LEADERS 509
10.5.3 PERVASIVE PLAYERS 509
10.5.4 PARTICIPANTS 509
FIGURE 36 DPCR AND QPCR MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 510
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 511
10.5.5.1 Overall footprint 511
FIGURE 37 DPCR AND QPCR MARKET: OVERALL FOOTPRINT 511
10.5.5.2 Offering footprint 512
TABLE 824 DPCR AND QPCR MARKET: OFFERING FOOTPRINT 512
10.5.5.3 Application footprint 513
TABLE 825 DPCR AND QPCR MARKET: APPLICATION FOOTPRINT 513
10.5.5.4 End-user footprint 514
TABLE 826 DPCR AND QPCR MARKET: END-USER FOOTPRINT 514
10.5.5.5 Region footprint 515
TABLE 827 DPCR AND QPCR MARKET: REGION FOOTPRINT 515
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 517
10.6.1 PROGRESSIVE COMPANIES 517
10.6.2 RESPONSIVE COMPANIES 517
10.6.3 DYNAMIC COMPANIES 517
10.6.4 STARTING BLOCKS 517
FIGURE 38 DPCR AND QPCR MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 518
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 519
TABLE 828 DPCR AND QPCR MARKET: KEY STARTUPS/SMES 519
TABLE 829 DPCR AND QPCR MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 520
10.7 COMPANY VALUATION & FINANCIAL METRICS 520
FIGURE 39 EV/EBITDA OF KEY DPCR AND QPCR VENDORS 520
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY DPCR AND QPCR VENDORS 521
10.8 BRAND/PRODUCT COMPARISON ANALYSIS 521
FIGURE 41 BRAND/PRODUCT COMPARISON ANALYSIS, BY DPCR AND QPCR OFFERINGS 521
10.9 COMPETITIVE SCENARIO 522
10.9.1 PRODUCT LAUNCHES & APPROVALS 522
TABLE 830 DPCR AND QPCR MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021?MAY 2024 522
10.9.2 DEALS 524
TABLE 831 DPCR AND QPCR MARKET: DEALS, JANUARY 2021-MAY 2024 524
10.9.3 EXPANSIONS 526
TABLE 832 DPCR AND QPCR MARKET: EXPANSIONS, JANUARY 2021-MAY 2024 526
11 COMPANY PROFILES 527
11.1 KEY PLAYERS 527
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 DANAHER CORPORATION 527
TABLE 833 DANAHER CORPORATION: COMPANY OVERVIEW 527
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2023) 528
TABLE 834 DANAHER CORPORATION: PRODUCTS OFFERED 529
TABLE 835 DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 531
TABLE 836 DANAHER CORPORATION: DEALS, JANUARY 2021-MAY 2024 531
11.1.2 F. HOFFMANN-LA ROCHE LTD. 533
TABLE 837 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 533
FIGURE 43 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023) 534
TABLE 838 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED 534
TABLE 839 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 536
TABLE 840 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021-MAY 2024 537
11.1.3 THERMO FISHER SCIENTIFIC INC. 538
TABLE 841 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 538
FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 539
TABLE 842 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 539
TABLE 843 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 544
TABLE 844 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-MAY 2024 546
11.1.4 MERCK KGAA 547
TABLE 845 MERCK KGAA: COMPANY OVERVIEW 547
FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2023) 548
TABLE 846 MERCK KGAA: PRODUCTS OFFERED 548
11.1.5 QIAGEN N.V. 553
TABLE 847 QIAGEN N.V.: COMPANY OVERVIEW 553
FIGURE 46 QIAGEN N.V.: COMPANY SNAPSHOT (2023) 554
TABLE 848 QIAGEN N.V.: PRODUCTS OFFERED 555
TABLE 849 QIAGEN N.V.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021-MAY 2024 560
TABLE 850 QIAGEN N.V.: DEALS, JANUARY 2021-MAY 2024 561
11.1.6 BIO-RAD LABORATORIES, INC. 562
TABLE 851 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 562
FIGURE 47 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023) 563
TABLE 852 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 563
TABLE 853 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 565
TABLE 854 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021-MAY 2024 566
11.1.7 AGILENT TECHNOLOGIES, INC. 567
TABLE 855 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 567
FIGURE 48 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023) 568
TABLE 856 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 569
TABLE 857 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 571
TABLE 858 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021-MAY 2024 571
11.1.8 TAKARA BIO INC. 572
TABLE 859 TAKARA BIO INC.: COMPANY OVERVIEW 572
FIGURE 49 TAKARA BIO INC.: COMPANY SNAPSHOT (2023) 573
TABLE 860 TAKARA BIO INC.: PRODUCTS OFFERED 574
TABLE 861 TAKARA BIO INC.: DEALS, JANUARY 2021-MAY 2024 575
11.1.9 BECTON, DICKINSON, AND COMPANY 576
TABLE 862 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 576
FIGURE 50 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023) 577
TABLE 863 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 577
TABLE 864 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 578
TABLE 865 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021-MAY 2024 579
11.1.10 ABBOTT LABORATORIES 580
TABLE 866 ABBOTT LABORATORIES: COMPANY OVERVIEW 580
FIGURE 51 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023) 581
11.1.10.2 Products offered 582
TABLE 867 ABBOTT LABORATORIES: PRODUCTS OFFERED 582
TABLE 868 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 582
11.1.11 PROMEGA CORPORATION 583
TABLE 869 PROMEGA CORPORATION: COMPANY OVERVIEW 583
TABLE 870 PROMEGA CORPORATION: PRODUCTS OFFERED 583
TABLE 871 PROMEGA CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 584
11.1.12 MERIDIAN BIOSCIENCE 585
TABLE 872 MERIDIAN BIOSCIENCE: COMPANY OVERVIEW 585
TABLE 873 MERIDIAN BIOSCIENCE: PRODUCTS OFFERED 586
TABLE 874 MERIDIAN BIOSCIENCE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 587
TABLE 875 MERIDIAN BIOSCIENCE: DEALS, JANUARY 2021-MAY 2024 588
11.1.13 ENDRESS+HAUSER GROUP SERVICES AG 589
TABLE 876 ENDRESS+HAUSER GROUP SERVICES AG: COMPANY OVERVIEW 589
FIGURE 52 ENDRESS+HAUSER GROUP SERVICES AG: COMPANY SNAPSHOT (2023) 590
TABLE 877 ENDRESS+HAUSER GROUP SERVICES AG: PRODUCTS OFFERED 591
TABLE 878 ENDRESS+HAUSER GROUP SERVICES AG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 592
TABLE 879 ENDRESS+HAUSER GROUP SERVICES AG: DEALS, JANUARY 2021-MAY 2024 592
11.1.14 BIOMERIEUX 593
TABLE 880 BIOMERIEUX: COMPANY OVERVIEW 593
FIGURE 53 BIOMERIEUX: COMPANY SNAPSHOT (2023) 594
TABLE 881 BIOMERIEUX: PRODUCTS OFFERED 595
TABLE 882 BIOMERIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 595
11.1.15 EPPENDORF AG 596
TABLE 883 EPPENDORF AG: COMPANY OVERVIEW 596
FIGURE 54 EPPENDORF AG: COMPANY SNAPSHOT (2023) 597
TABLE 884 EPPENDORF AG: PRODUCTS OFFERED 597
11.1.16 QUIDELORTHO CORPORATION 598
TABLE 885 QUIDELORTHO CORPORATION: COMPANY OVERVIEW 598
FIGURE 55 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2023) 599
TABLE 886 QUIDELORTHO CORPORATION: PRODUCTS OFFERED 599
TABLE 887 QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 600
TABLE 888 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021-MAY 2024 600
11.1.17 ENZO BIOCHEM INC. 601
TABLE 889 ENZO BIOCHEM INC.: COMPANY OVERVIEW 601
FIGURE 56 ENZO BIOCHEM INC.: COMPANY SNAPSHOT (2023) 601
TABLE 890 ENZO BIOCHEM INC.: PRODUCTS OFFERED 602
TABLE 891 ENZO BIOCHEM INC.: DEALS, JANUARY 2021-MAY 2024 604
11.1.18 LEPU MEDICAL TECHNOLOGY CO., LTD. 605
TABLE 892 LEPU MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 605
FIGURE 57 LEPU MEDICAL TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT (2023) 605
TABLE 893 LEPU MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED 606
11.1.19 SYSMEX CORPORATION 607
TABLE 894 SYSMEX CORPORATION: COMPANY OVERVIEW 607
FIGURE 58 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023) 607
TABLE 895 SYSMEX CORPORATION: PRODUCTS OFFERED 608
11.2 STARTUP/SME PLAYERS 608
11.2.1 BIOCARTIS 608
TABLE 896 BIOCARTIS: COMPANY OVERVIEW 608
11.2.2 STILLA 609
TABLE 897 STILLA: COMPANY OVERVIEW 609
11.2.3 ANTYLIA SCIENTIFIC 610
TABLE 898 ANTYLIA SCIENTIFIC: COMPANY OVERVIEW 610
11.2.4 BIONEER CORPORATION 611
TABLE 899 BIONEER CORPORATION: COMPANY OVERVIEW 611
11.2.5 STANDARD BIOTOOLS 613
TABLE 900 STANDARD BIOTOOLS: COMPANY OVERVIEW 613
11.2.6 SEEGENE INC. 614
TABLE 901 SEEGENE INC.: COMPANY OVERVIEW 614
11.2.7 GENSCRIPT 616
TABLE 902 GENSCRIPT: COMPANY OVERVIEW 616
11.2.8 LGC BIOSEARCH TECHNOLOGIES 617
TABLE 903 LGC BIOSEARCH TECHNOLOGIES: COMPANY OVERVIEW 617
11.2.9 QUANTABIO 619
TABLE 904 QUANTABIO: COMPANY OVERVIEW 619
11.2.10 RANDOX LABORATORIES LTD. 620
TABLE 905 RANDOX LABORATORIES LTD.: COMPANY OVERVIEW 620
11.2.11 NEW ENGLAND BIOLABS 621
TABLE 906 NEW ENGLAND BIOLABS: COMPANY OVERVIEW 621
11.2.12 PCR BIOSYSTEMS 622
TABLE 907 PCR BIOSYSTEMS: COMPANY OVERVIEW 622
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
?
12 APPENDIX 623
12.1 DISCUSSION GUIDE 623
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 629
12.3 CUSTOMIZATION OPTIONS 631
12.4 RELATED REPORTS 631
12.5 AUTHOR DETAILS 632

  • Not Sure / Need Reassuring
    • Confirm Content

      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages

      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives

      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices

      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts

      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies

      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses

      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License

      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats

      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery

      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges

      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card

      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer

      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security

      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security

      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $4950.00
  • $6650.00
  • $8150.00
  • $10000.00
  • ADD TO BASKET
  • BUY NOW

Related Reports

Biopharmaceuticals Contract Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
 Market Report I 2025-04-28 I 120 Pages
Gene Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
 Market Report I 2025-04-28 I 124 Pages
Lab Automation In Genomics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
 Market Report I 2025-04-28 I 120 Pages

Don't forget we can help save time with your search, contact us and we'll prepare and send options

Cell Isolation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
 Market Report I 2025-04-28 I 120 Pages
DNA Sequencing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
 Market Report I 2025-04-28 I 131 Pages